| Brenda J. Pittman | |
|
506 Maysville Rd, Suite 2, Mt Sterling, KY 40353-9317 | |
| (859) 432-8168 | |
| (859) 432-8163 |
| Full Name | Brenda J. Pittman |
|---|---|
| Type | Facility |
| Speciality | Nurse Practitioner - Family |
| Location | 506 Maysville Rd, Mt Sterling, Kentucky |
| Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407187941 | NPI | - | NPPES |
| 78012085 | Medicaid | KY | |
| 1609884287 | Other | NPI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 111N00000X | Chiropractor | (* (Not Available)) | Secondary |
| 363LF0000X | Nurse Practitioner - Family | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Brenda J. Pittman 506 N Maysville Road, Suite 2, Mt Sterling, KY 40353-9679 Ph: (859) 432-8168 | Brenda J. Pittman 506 Maysville Rd, Suite 2, Mt Sterling, KY 40353-9317 Ph: (859) 432-8168 |
News Archive
The White House is poised to release the country's first comprehensive domestic strategy against AIDS, as funds to prevent infections have failed to halt the epidemic in those most at risk of the disease, AIDS groups said. Release of the National AIDS Strategy may come as early as today, fulfilling Obama's campaign pledge to unify priorities among federal agencies and state partners, said Mitchell Warren.
NaturalNano, Inc. announced today that Dr. Michael King, a researcher at Cornell University, has published a new study demonstrating how NaturalNano nanotubes can improve targeting of circulating tumor cells (CTC's). These nanotubes, when added to the surface where cancer cells are attracted, enhance the natural rolling mechanism that Dr. King believes will allow them to be exposed to specific drugs or other therapeutic agents, or isolated for diagnostic and research purposes.
A three-drug cocktail can eliminate the hepatitis C virus in patients far more effectively than the current two-drug regimen, according to researchers at Henry Ford Hospital.
Now, a new study by researchers from the University of Michigan and published on the online preprint server medRxiv* in June 2020 shows that the cytokine inhibitor tocilizumab could have a favorable effect on survival in the most severely infected patients who require mechanical ventilation. This needs to be confirmed by clinical trials.
UT Southwestern Medical Center is leading a Texas consortium of researchers to establish the country's first National Center for Heavy Ion Radiation Therapy that could provide clinical care and research using heavy particles for innovative new cancer treatments.
› Verified 5 days ago